Phase II study of Sorafenib (BAY 43-9006) in combination with Gemcitabine in recurrent epithelial ovarian cancer - a study of the PMH phase II consortium Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Townsley, C
  • Hirte, H
  • Sharma, S
  • Pond, Gregory
  • Tinker, L
  • Afinec, A
  • Wright, J
  • Oza, AM

publication date

  • October 1, 2005